You are now leaving Abacavir HSR Support. ViiV/GSK do not recommend, endorse or accept liability for sites controlled by third parties.
Report adverse events
If you want to report an adverse event, please contact the Drug Safety Unit at GlaxoSmithKline, Phone: 08-638 93 00 (ask for the Drug Safety Unit). In addition you can use the . Please choose the relevant ViiV Healthcare medicine from the drop-down product list on the form.
If the suspected adverse event involves a pregnancy exposure, please consider enrolling your patient on the *. This is a voluntary prospective, exposure-registration, observational study designed to collect and evaluate data on the outcomes of pregnancy exposures to antiretroviral products. It is intended to provide an early signal of any major teratogenic effect associated with a prenatal exposure to the products monitored through the Registry. Healthcare providers are asked to prospectively (before outcome of pregnancy is known) register women who have been exposed during pregnancy to the medications followed in the Registry. Patient confidentiality is strictly guarded, with no identifying patient information collected.
* ViiV Healthcare does not recommend, endorse or accept liability for sites controlled by third parties.